Cargando…
Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report
Capicua transcriptional repressor (CIC)-rearranged sarcoma is an Ewing-like sarcoma with an aggressive clinical course and poor prognosis. No standard treatment has been established. The present study describes a case of CIC-rearranged sarcoma with lung metastases developing in a 24-year-old woman a...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890439/ https://www.ncbi.nlm.nih.gov/pubmed/33680459 http://dx.doi.org/10.3892/mco.2021.2230 |
_version_ | 1783652514945564672 |
---|---|
author | Kimbara, Shiro Imamura, Yoshinori Kiyota, Naomi Takakura, Hidetomo Matsumoto, Sakuya Koyama, Taiji Fujishima, Yoshimi Funakoshi, Yohei Toyoda, Masanori Hirose, Takanori Kanzawa, Maki Kawamoto, Teruya Hara, Hitomi Minami, Hironobu |
author_facet | Kimbara, Shiro Imamura, Yoshinori Kiyota, Naomi Takakura, Hidetomo Matsumoto, Sakuya Koyama, Taiji Fujishima, Yoshimi Funakoshi, Yohei Toyoda, Masanori Hirose, Takanori Kanzawa, Maki Kawamoto, Teruya Hara, Hitomi Minami, Hironobu |
author_sort | Kimbara, Shiro |
collection | PubMed |
description | Capicua transcriptional repressor (CIC)-rearranged sarcoma is an Ewing-like sarcoma with an aggressive clinical course and poor prognosis. No standard treatment has been established. The present study describes a case of CIC-rearranged sarcoma with lung metastases developing in a 24-year-old woman as a therapy-associated malignancy following chemotherapy for anaplastic large cell lymphoma at nine years old. This was treated with palliative regimens used for Ewing sarcoma. The patient achieved disease control for one year. Of note, ifosfamide and etoposide (IE), which were used as a second line treatment lead to a partial response. The case described in the present study indicated that treatment with Ewing regimens is a reasonable option for patients with metastatic CIC-rearranged sarcoma, including those with a second malignant case. |
format | Online Article Text |
id | pubmed-7890439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-78904392021-03-05 Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report Kimbara, Shiro Imamura, Yoshinori Kiyota, Naomi Takakura, Hidetomo Matsumoto, Sakuya Koyama, Taiji Fujishima, Yoshimi Funakoshi, Yohei Toyoda, Masanori Hirose, Takanori Kanzawa, Maki Kawamoto, Teruya Hara, Hitomi Minami, Hironobu Mol Clin Oncol Articles Capicua transcriptional repressor (CIC)-rearranged sarcoma is an Ewing-like sarcoma with an aggressive clinical course and poor prognosis. No standard treatment has been established. The present study describes a case of CIC-rearranged sarcoma with lung metastases developing in a 24-year-old woman as a therapy-associated malignancy following chemotherapy for anaplastic large cell lymphoma at nine years old. This was treated with palliative regimens used for Ewing sarcoma. The patient achieved disease control for one year. Of note, ifosfamide and etoposide (IE), which were used as a second line treatment lead to a partial response. The case described in the present study indicated that treatment with Ewing regimens is a reasonable option for patients with metastatic CIC-rearranged sarcoma, including those with a second malignant case. D.A. Spandidos 2021-04 2021-02-08 /pmc/articles/PMC7890439/ /pubmed/33680459 http://dx.doi.org/10.3892/mco.2021.2230 Text en Copyright: © Kimbara et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Kimbara, Shiro Imamura, Yoshinori Kiyota, Naomi Takakura, Hidetomo Matsumoto, Sakuya Koyama, Taiji Fujishima, Yoshimi Funakoshi, Yohei Toyoda, Masanori Hirose, Takanori Kanzawa, Maki Kawamoto, Teruya Hara, Hitomi Minami, Hironobu Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report |
title | Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report |
title_full | Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report |
title_fullStr | Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report |
title_full_unstemmed | Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report |
title_short | Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report |
title_sort | secondary cic-rearranged sarcoma responsive to chemotherapy regimens for ewing sarcoma: a case report |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890439/ https://www.ncbi.nlm.nih.gov/pubmed/33680459 http://dx.doi.org/10.3892/mco.2021.2230 |
work_keys_str_mv | AT kimbarashiro secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT imamurayoshinori secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT kiyotanaomi secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT takakurahidetomo secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT matsumotosakuya secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT koyamataiji secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT fujishimayoshimi secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT funakoshiyohei secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT toyodamasanori secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT hirosetakanori secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT kanzawamaki secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT kawamototeruya secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT harahitomi secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport AT minamihironobu secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport |